Boston Scientific Corp (BSX) shareholders
Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 113,006,671 | 7.60% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 111,127,205 | 7.47% | 13G (passive) | Mar 31, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (7.50%) | 110,320,938 | 7.50% | 13G (passive) amendment | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BSX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 129,680,916 | 8.95% | $5.53B | −2,141,121 | 0.08% |
| Vanguard Capital Management LLC | 97,087,553 | 6.70% | $4.14B | +675,985 | 0.09% |
| State Street Corp | 70,111,196 | 4.84% | $2.99B | +2,124,349 | 0.09% |
| Primecap Management Co/Ca/ | 50,520,914 | 3.49% | $2.16B | +17,991,140 | 1.28% |
| FMR LLC | 45,702,845 | 3.15% | $1.95B | −28,523,550 | 0.08% |
| Geode Capital Management, LLC | 33,440,102 | 2.31% | $1.42B | +154,345 | 0.08% |
| Vanguard Portfolio Management LLC | 29,792,794 | 2.06% | $1.27B | −3,417 | 0.06% |
| D. E. Shaw & Co., Inc. | 25,457,409 | 1.76% | $1.09B | +1,145,057 | 0.52% |
| Massachusetts Financial Services Co /Ma/ | 24,859,191 | 1.72% | $1.50B | +13,862,619 | 0.48% |
| JPMorgan Chase & Co | 23,907,838 | 1.65% | $1.04B | −9,442,319 | 0.06% |
| Arrowstreet Capital, Limited Partnership | 23,293,913 | 1.61% | $994.18M | +9,402,245 | 0.44% |
| Norges Bank | 21,170,029 | 1.46% | $903.54M | New | 0.09% |
| Two Sigma Investments, LP | 19,359,023 | 1.34% | $826.24M | +9,947,792 | 0.60% |
| Morgan Stanley | 18,947,147 | 1.31% | $808.66M | −3,319,517 | 0.04% |
| Jupiter Topco LLC | 18,822,853 | 1.30% | $803.36M | New | 0.33% |
| Bollard Group LLC | 18,420,720 | 1.27% | $786.20M | −111,453 | 23.93% |
| Goldman Sachs Group Inc | 16,954,342 | 1.17% | $723.61M | −1,937,282 | 0.06% |
| Capital World Investors | 16,812,257 | 1.16% | $717.60M | +1,502,519 | 0.08% |
| UBS Group AG | 16,352,420 | 1.13% | $697.92M | +1,527,758 | 0.09% |
| Wellington Management Group Llp | 15,301,828 | 1.06% | $653.08M | −3,531,578 | 0.11% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,474 | 1.34B | 92.1% | 147 / 587 | 614 / 326 | 206M | 198M |
| Q1 2026 | 1,679 | 1.34B | 92.8% | 196 / 677 | 637 / 280 | 313M | 197M |
| Q4 2025 | 1,790 | 1.37B | 94.6% | 235 / 668 | 692 / 129 | 130M | 129M |
| Q3 2025 | 1,716 | 1.38B | 95.1% | 179 / 768 | 559 / 131 | 125M | 107M |
| Q2 2025 | 1,694 | 1.36B | 93.9% | 156 / 754 | 552 / 91 | 91M | 78M |
| Q1 2025 | 1,648 | 1.35B | 93.2% | 231 / 668 | 555 / 74 | 88M | 68M |
| Q4 2024 | 1,519 | 1.34B | 92.7% | 220 / 618 | 492 / 84 | 79M | 83M |
| Q3 2024 | 1,402 | 1.35B | 93.2% | 166 / 565 | 478 / 76 | 179M | 59M |
| Q2 2024 | 1,323 | 1.36B | 93.7% | 171 / 554 | 419 / 53 | 74M | 98M |
| Q1 2024 | 1,226 | 1.40B | 96.3% | 158 / 441 | 452 / 70 | 90M | 68M |
| Q4 2023 | 1,151 | 1.39B | 95.7% | 178 / 442 | 377 / 68 | 122M | 73M |
| Q3 2023 | 1,059 | 1.34B | 92.4% | 99 / 440 | 353 / 95 | 82M | 63M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
978 funds held BSX in Q2 2026, 40% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BSX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 47,181,284 | 3.26% | $2.01B | 0.09% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 38,518,788 | 2.66% | $1.64B | 0.10% | Jun 30, 2026 |
| Vanguard Primecap Fund | 30,831,039 | 2.13% | $1.32B | 1.37% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 20,445,345 | 1.41% | $872.61M | 0.10% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 18,978,237 | 1.31% | $916.84M | 0.11% | May 31, 2026 |
| Growth Fund of America | 13,027,839 | 0.90% | $629.37M | 0.17% | May 31, 2026 |
| Vanguard Health Care Fund | 12,474,112 | 0.86% | $582.92M | 1.53% | Jul 31, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 10,500,647 | 0.72% | $448.17M | 1.10% | Jun 30, 2026 |
| Vanguard Growth Index Fund | 9,210,339 | 0.64% | $393.10M | 0.10% | Jun 30, 2026 |
| Vanguard Capital Opportunity Fund | 8,820,206 | 0.61% | $376.45M | 1.15% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 8,069,042 | 0.56% | $344.39M | 0.10% | Jun 30, 2026 |
| Vanguard Value Index Fund | 7,086,757 | 0.49% | $302.46M | 0.12% | Jun 30, 2026 |
| AMCAP Fund | 6,913,184 | 0.48% | $333.98M | 0.34% | May 31, 2026 |
| Janus Henderson Enterprise Fund | 6,658,970 | 0.46% | $284.20M | 1.27% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 6,238,651 | 0.43% | $301.39M | 0.12% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael F. Mahoney | Chairman, President & CEO, Director | 1,864,377 | 0.13% | Nov 6, 2026 |
| Miriam O'Sullivan | SVP, Chief HR Officer | 21,296 | 0.00% | Nov 3, 2026 |
| Padraig Andrew O'Connor | EVP, Global Operations | 7,892 | 0.00% | Sep 3, 2026 |
| Emily Woodworth | SVP, Global Controller and CAO | 6,053 | 0.00% | Aug 12, 2026 |
| Jonathan Monson | EVP and CFO | 48,971 | 0.00% | Aug 11, 2026 |
| Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 283,339 | 0.02% | Aug 3, 2026 |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | 78,122 | 0.01% | May 4, 2026 |
| Vance R. Brown | EVP, GC and Corp. Secretary | 55,134 | 0.00% | Feb 18, 2026 |
| John Bradley Sorenson | EVP, Global Operations | 18,705 | 0.00% | May 6, 2025 |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 50,766 | 0.00% | Feb 25, 2025 |
| Daniel J. Brennan | EVP and CFO | 283,658 | 0.02% | Feb 19, 2025 |
| Wendy Carruthers | EVP, Human Resources | 29,308 | 0.00% | Dec 4, 2024 |
| Susan E. Morano | Director | 13,784 | 0.00% | Aug 26, 2026 |
| David C. Habiger | Director | 17,160 | 0.00% | Aug 7, 2026 |
| Edward J. Ludwig | Director | 30,359 | 0.00% | Aug 3, 2026 |
| Cheryl Pegus | Director | 1,770 | 0.00% | May 21, 2026 |
| Christophe Pierre Weber | Director | 2,646 | 0.00% | May 11, 2026 |
| David S. Wichmann | Director | 45,382 | 0.00% | May 11, 2026 |
| Cathy R. Smith | Director | 141 | 0.00% | May 11, 2026 |
| Jessica L. Mega | Director | 12,035 | 0.00% | May 11, 2026 |
| Ellen M. Zane | Director | 27,934 | 0.00% | May 11, 2026 |
| Yoshiaki Fujimori | Director | 2,081 | 0.00% | Jul 30, 2025 |
| John E. Sununu | Director | 54,723 | 0.00% | May 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael F. Mahoney Chairman, President & CEO, Director | Nov 4, 2026 | Gift | +102,249 | – | – | 252,241 |
| Michael F. Mahoney Chairman, President & CEO, Director | Nov 4, 2026 | Gift | +149,992 | – | – | 149,992 |
| Miriam O'Sullivan SVP, Chief HR Officer | Nov 1, 2026 | Tax withholding | −1,872 | $41.98 | $78.59K | 19,565 |
| Miriam O'Sullivan SVP, Chief HR Officer | Nov 1, 2026 | Option exercise | +3,871 | – | – | 21,437 |
| Padraig Andrew O'Connor EVP, Global Operations | Sep 2, 2026 | Tax withholding | −567 | $48.37 | $27.43K | 7,892 |
| Padraig Andrew O'Connor EVP, Global Operations | Sep 2, 2026 | Option exercise | +1,171 | – | – | 8,459 |
| Susan E. Morano Director | Aug 25, 2026 | Buy | +2,040 | $49.22 | $100.41K | 13,784 |
| Emily Woodworth SVP, Global Controller and CAO | Aug 11, 2026 | Discretionary | +2,930 | $51.19 | $149.99K | 2,930 |
| Jonathan Monson EVP and CFO | Aug 10, 2026 | Discretionary | +9,908 | $50.46 | $499.96K | 9,908 |
| David C. Habiger Director | Aug 5, 2026 | Buy | +2,100 | $47.59 | $99.94K | 17,160 |
| David C. Habiger Director | Aug 4, 2026 | Buy | +140 | $48.59 | $6.80K | 15,060 |
| Michael F. Mahoney Chairman, President & CEO, Director | Aug 3, 2026 | Discretionary | +22,119 | $48.43 | $1.07M | 22,119 |
| Michael F. Mahoney Chairman, President & CEO, Director | Aug 3, 2026 | Buy | +186,240 | $48.33 | $9.00M | 1,590,024 |
| David C. Habiger Director | Aug 3, 2026 | Buy | +1,042 | $48.07 | $50.09K | 14,920 |
| Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | Jul 31, 2026 | Discretionary | +64,198 | $46.73 | $3.00M | 64,198 |
| Edward J. Ludwig Director | Jul 31, 2026 | Buy | +5,000 | $45.48 | $227.40K | 30,359 |
| Jonathan Monson EVP and CFO | Jul 1, 2026 | Tax withholding | −1,010 | $43.06 | $43.49K | 39,063 |
| Jonathan Monson EVP and CFO | Jul 1, 2026 | Option exercise | +2,087 | – | – | 40,073 |
| Michael F. Mahoney Chairman, President & CEO, Director | May 28, 2026 | Gift | −386,755 | – | – | 0 |
| Cheryl Pegus Director | May 20, 2026 | Buy | +1,770 | $56.49 | $99.99K | 1,770 |
| David C. Habiger Director | May 20, 2026 | Buy | +2,250 | $55.92 | $125.82K | 13,878 |
| Edward J. Ludwig Director | May 20, 2026 | Buy | +3,580 | $56.68 | $202.91K | 25,359 |
| David C. Habiger Director | May 19, 2026 | Buy | +2,200 | $56.95 | $125.29K | 11,628 |
| Edward J. Ludwig Director | May 7, 2026 | Award | +3,800 | – | – | 21,779 |
| Christophe Pierre Weber Director | May 7, 2026 | Award | +1,767 | – | – | 2,646 |
| Christophe Pierre Weber Director | May 7, 2026 | Award | +1,140 | – | – | 3,786 |
| Susan E. Morano Director | May 7, 2026 | Award | +3,800 | – | – | 10,463 |
| Susan E. Morano Director | May 7, 2026 | Award | +1,281 | – | – | 11,744 |
| Ellen M. Zane Director | May 7, 2026 | Award | +3,800 | – | – | 27,934 |
| Jessica L. Mega Director | May 7, 2026 | Award | +3,800 | – | – | 12,035 |
| David S. Wichmann Director | May 7, 2026 | Award | +3,800 | – | – | 45,382 |
| David C. Habiger Director | May 7, 2026 | Award | +3,800 | – | – | 9,428 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | May 2, 2026 | Option exercise | +2,102 | – | – | 57,894 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | May 2, 2026 | Tax withholding | −1,007 | $56.50 | $56.90K | 56,887 |
| Padraig Andrew O'Connor EVP, Global Operations | May 2, 2026 | Option exercise | +1,802 | – | – | 7,896 |
| Padraig Andrew O'Connor EVP, Global Operations | May 2, 2026 | Tax withholding | −872 | $56.50 | $49.27K | 7,024 |
| Christophe Pierre Weber Director | Mar 2, 2026 | Award | +323 | – | – | 879 |
| Christophe Pierre Weber Director | Mar 2, 2026 | Award | +556 | – | – | 556 |
| Susan E. Morano Director | Mar 2, 2026 | Award | +24 | – | – | 6,663 |
| Emily Woodworth SVP, Global Controller and CAO | Mar 1, 2026 | Tax withholding | −372 | $76.85 | $28.59K | 2,859 |
| Emily Woodworth SVP, Global Controller and CAO | Mar 1, 2026 | Option exercise | +838 | – | – | 3,231 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | Feb 19, 2026 | Discretionary | +6,851 | $75.76 | $519.03K | 20,205 |
| Miriam O'Sullivan SVP, Chief HR Officer | Feb 16, 2026 | Option exercise | +990 | – | – | 17,593 |
| Miriam O'Sullivan SVP, Chief HR Officer | Feb 16, 2026 | Tax withholding | −291 | $74.73 | $21.75K | 17,302 |
| Padraig Andrew O'Connor EVP, Global Operations | Feb 16, 2026 | Option exercise | +905 | – | – | 6,433 |
| Padraig Andrew O'Connor EVP, Global Operations | Feb 16, 2026 | Tax withholding | −339 | $74.73 | $25.33K | 6,094 |
| Emily Woodworth SVP, Global Controller and CAO | Feb 16, 2026 | Tax withholding | −283 | $74.73 | $21.15K | 2,393 |
| Emily Woodworth SVP, Global Controller and CAO | Feb 16, 2026 | Option exercise | +637 | – | – | 2,676 |
| Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | Feb 16, 2026 | Option exercise | +3,960 | – | – | 215,713 |
| Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | Feb 16, 2026 | Tax withholding | −1,806 | $74.73 | $134.96K | 213,907 |
| Jonathan Monson EVP and CFO | Feb 16, 2026 | Option exercise | +990 | – | – | 38,426 |
| Jonathan Monson EVP and CFO | Feb 16, 2026 | Tax withholding | −440 | $74.73 | $32.88K | 37,986 |
| Michael F. Mahoney Chairman, President & CEO, Director | Feb 16, 2026 | Tax withholding | −7,865 | $74.73 | $587.75K | 1,576,860 |
| Michael F. Mahoney Chairman, President & CEO, Director | Feb 16, 2026 | Option exercise | +16,265 | – | – | 1,584,725 |
| Vance R. Brown EVP, GC and Corp. Secretary | Feb 16, 2026 | Option exercise | +1,839 | – | – | 55,134 |
| Vance R. Brown EVP, GC and Corp. Secretary | Feb 16, 2026 | Tax withholding | −890 | $74.73 | $66.51K | 54,244 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | Feb 16, 2026 | Tax withholding | −1,229 | $74.73 | $91.84K | 55,792 |
| Arthur C. Butcher EVP& Grp Pres, MedSurg & APAC | Feb 16, 2026 | Option exercise | +2,546 | – | – | 57,021 |
| Miriam O'Sullivan SVP, Chief HR Officer | Feb 14, 2026 | Option exercise | +1,124 | – | – | 16,932 |
| Miriam O'Sullivan SVP, Chief HR Officer | Feb 14, 2026 | Tax withholding | −329 | $74.73 | $24.59K | 16,603 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Boston Scientific's stock actually held short. Settlement fails (shares not delivered on time) peaked at 28,890 shares on Aug 20, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Michael F. Mahoney Officer, Director | Feb 2, 2026 | 160,901 | $15.04M | Feb 2, 2026 | Performance Shares |
| Arthur C. Butcher Officer | Dec 1, 2025 | 17,313 | $1.76M | Dec 1, 2025 | Stock Option Exercise |
| Ellen M. Zane Director | Nov 6, 2025 | 2,901 | $284.17K | Nov 6, 2025 | stock grant |
| Joseph Michael Fitzgerald Officer | Nov 3, 2025 | 50,000 | $4.97M | Nov 3, 2025 | Stock Option Exercise |
| Ellen M. Zane Director | Oct 28, 2025 | 2,901 | $296.59K | Oct 28, 2025 | Stock Grant |
| Ellen M. Zane Director | Oct 27, 2025 | 9,990 | $1.01M | Oct 27, 2025 | Stock Grant |
| Joseph Michael Fitzgerald Officer | Oct 1, 2025 | 50,000 | $4.92M | Oct 1, 2025 | Stock Option Exercise |
| Joseph Michael Fitzgerald Officer | Sep 2, 2025 | 50,000 | $5.27M | Sep 2, 2025 | Stock Option Exercise |
| Joseph Michael Fitzgerald Officer | Aug 1, 2025 | 50,000 | $5.23M | Aug 1, 2025 | Stock Option Exercise |
| Arthur C. Butcher Officer | Aug 1, 2025 | 17,313 | $1.81M | Aug 1, 2025 | Stock Option Exercise |
| Yoshiaki Fujimori Director | Jul 29, 2025 | 2,901 | $310.38K | Jul 29, 2025 | Restricted Stock |
| Edward J. Ludwig Director | Jul 25, 2025 | 4,000 | $429.84K | Jul 25, 2025 | RSU Granted Shares |
| Joseph Michael Fitzgerald Officer | Jul 1, 2025 | 50,000 | $5.35M | Jul 1, 2025 | Stock Option Exercise |
| Joseph Michael Fitzgerald Officer | Jun 4, 2025 | 56,372 | $5.80M | Jun 4, 2025 | Stock Option Exercise |
| Michael F. Mahoney Officer, Director | Jun 2, 2025 | 164,443 | $17.05M | Jun 2, 2025 | Restricted Stock |
Congress trades
40 trades in Boston Scientific reported by 9 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Kevin Hern OK01 · joint account | Sold | Sep 9, 2026 | $50K–100K | Sep 25, 2026 |
| Kevin Hern OK01 · joint account | Sold (part) | Sep 4, 2026 | $50K–100K | Sep 25, 2026 |
| Kevin Hern OK01 · child | Sold | Sep 3, 2026 | $1K–15K | Sep 25, 2026 |
| Kevin Hern OK01 · child | Sold | Sep 3, 2026 | $1K–15K | Sep 25, 2026 |
| Kevin Hern OK01 · child | Sold | Sep 3, 2026 | $1K–15K | Sep 25, 2026 |
| Kevin Hern OK01 · joint account | Sold | Aug 31, 2026 | $15K–50K | Sep 25, 2026 |
| Gilbert Cisneros CA31 | Bought | Aug 18, 2026 | $1K–15K | Sep 10, 2026 |
| Rohit Khanna CA17 · child | Bought | Aug 10, 2026 | $1K–15K | Sep 4, 2026 |
| Gilbert Cisneros CA31 | Sold (part) | Jun 5, 2026 | $1K–15K | Jul 2, 2026 |
| Gilbert Cisneros CA31 | Bought | Jun 5, 2026 | $1K–15K | Jul 2, 2026 |
| Gilbert Cisneros CA31 | Bought | May 29, 2026 | $1K–15K | Jun 8, 2026 |
| Gilbert Cisneros CA31 | Bought | May 19, 2026 | $1K–15K | Jun 8, 2026 |
| Gilbert Cisneros CA31 | Bought | May 11, 2026 | $1K–15K | Jun 8, 2026 |
| Rohit Khanna CA17 · child | Bought | Mar 30, 2026 | $15K–50K | Apr 7, 2026 |
| Gilbert Cisneros CA31 | Bought | Feb 10, 2026 | $1K–15K | Mar 9, 2026 |
| Gilbert Cisneros CA31 | Bought | Jan 30, 2026 | $1K–15K | Feb 13, 2026 |
| Gilbert Cisneros CA31 | Sold (part) | Dec 24, 2025 | $1K–15K | Jan 12, 2026 |
| Gilbert Cisneros CA31 | Bought | Nov 18, 2025 | $1K–15K | Dec 15, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 31, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Kevin Hern OK01 · joint account | Sold (part) | Oct 28, 2025 | $15K–50K | Nov 16, 2025 |
| Gilbert Cisneros CA31 | Bought | Oct 17, 2025 | $1K–15K | Nov 18, 2025 |
| Valerie Hoyle OR04 · spouse | Sold | Sep 23, 2025 | $1K–15K | Oct 10, 2025 |
| Lisa McClain MI09 · spouse | Sold (part) | Aug 4, 2025 | $1K–15K | Sep 12, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | Jul 31, 2025 | $1K–15K | Aug 14, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | Jun 26, 2025 | $1K–15K | Jul 10, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | Jun 11, 2025 | $1K–15K | Jul 10, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | May 13, 2025 | $1K–15K | Jun 6, 2025 |
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $15K–50K | Jun 22, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | Apr 28, 2025 | $1K–15K | May 6, 2025 |
| Bruce Westerman AR04 | Sold | Apr 21, 2025 | $1K–15K | May 12, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | Mar 17, 2025 | $1K–15K | Apr 7, 2025 |
| Bruce Westerman AR04 | Bought | Mar 3, 2025 | $1K–15K | Apr 16, 2025 |
| Gilbert Cisneros CA31 | Sold (part) | Feb 24, 2025 | $1K–15K | Mar 6, 2025 |
| Lisa McClain MI09 · spouse | Bought | Dec 11, 2024 | $1K–15K | Aug 13, 2025 245 days late |
| Valerie Hoyle OR04 · spouse | Bought | Oct 29, 2024 | $1K–15K | Sep 12, 2025 318 days late |
| Rohit Khanna CA17 · child | Bought | Dec 5, 2023 | $1K–15K | Jan 4, 2024 |
| John Curtis UT03 · joint account | Sold | Dec 4, 2023 | $1K–15K | Dec 15, 2023 |
| Lois Frankel FL22 | Sold | Sep 8, 2023 | $1K–15K | Oct 10, 2023 |
See a number that looks wrong?